Carregant...

Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders

Background: Rare cancers occur with an incidence of no more than six cases per 100,000 people according to the definition used by the Surveillance of Rare Cancers in Europe project. For a variety of reasons (low prevalence, cytotoxicity), it is challenging to perform the necessary clinical studies t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: M Dooms, R Saesen, I Steemans, J Lansens, I Huys
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-05-01
Col·lecció:Frontiers in Pharmacology
Matèries:
Accés en línia:https://www.frontiersin.org/articles/10.3389/fphar.2022.775217/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!